HALO logo

Halozyme Therapeutics (HALO) Gross profit

Annual gross profit:

$855.91M+$219.01M(+34.39%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual gross profit is $855.91 million, with the most recent change of +$219.01 million (+34.39%) on December 31, 2024.
  • During the last 3 years, HALO annual gross profit has risen by +$494.01 million (+136.51%).
  • HALO annual gross profit is now at all-time high.

Performance

HALO Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

quarterly gross profit:

$216.46M-$39.49M(-15.43%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly gross profit is $216.46 million, with the most recent change of -$39.49 million (-15.43%) on March 31, 2025.
  • Over the past year, HALO quarterly gross profit has increased by +$48.91 million (+29.19%).
  • HALO quarterly gross profit is now -15.43% below its all-time high of $255.95 million, reached on December 31, 2024.

Performance

HALO quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

TTM gross profit:

$904.82M+$48.91M(+5.71%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO TTM gross profit is $904.82 million, with the most recent change of +$48.91 million (+5.71%) on March 31, 2025.
  • Over the past year, HALO TTM gross profit has increased by +$227.35 million (+33.56%).
  • HALO TTM gross profit is now at all-time high.

Performance

HALO TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

HALO Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.4%+29.2%+33.6%
3 y3 years+136.5%+113.6%+130.6%
5 y5 years+468.9%+1006.2%+668.7%

HALO Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+136.5%-15.4%+113.6%at high+130.6%
5 y5-yearat high+468.9%-15.4%+1006.2%at high+668.7%
alltimeall timeat high>+9999.0%-15.4%>+9999.0%at high>+9999.0%

HALO Gross profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$216.46M(-15.4%)
$904.82M(+5.7%)
Dec 2024
$855.91M(+34.4%)
$255.95M(+6.4%)
$855.91M(+10.1%)
Sep 2024
-
$240.66M(+25.5%)
$777.70M(+11.4%)
Jun 2024
-
$191.75M(+14.4%)
$698.25M(+3.1%)
Mar 2024
-
$167.55M(-5.7%)
$677.47M(+6.4%)
Dec 2023
$636.89M(+22.3%)
$177.74M(+10.3%)
$636.89M(+6.4%)
Sep 2023
-
$161.21M(-5.7%)
$598.53M(-0.1%)
Jun 2023
-
$170.97M(+34.6%)
$598.97M(+9.6%)
Mar 2023
-
$126.97M(-8.9%)
$546.43M(+4.9%)
Dec 2022
$520.81M(+43.9%)
$139.38M(-13.8%)
$520.81M(+12.8%)
Sep 2022
-
$161.66M(+36.5%)
$461.85M(+16.2%)
Jun 2022
-
$118.42M(+16.8%)
$397.44M(+1.3%)
Mar 2022
-
$101.36M(+26.0%)
$392.45M(+8.4%)
Dec 2021
$361.90M(+61.4%)
$80.42M(-17.3%)
$361.90M(-4.0%)
Sep 2021
-
$97.24M(-14.3%)
$376.91M(+11.0%)
Jun 2021
-
$113.44M(+60.2%)
$339.42M(+23.2%)
Mar 2021
-
$70.80M(-25.8%)
$275.46M(+22.9%)
Dec 2020
$224.23M(+49.0%)
$95.43M(+59.7%)
$224.23M(+35.3%)
Sep 2020
-
$59.75M(+20.7%)
$165.77M(+27.6%)
Jun 2020
-
$49.48M(+152.9%)
$129.92M(+10.4%)
Mar 2020
-
$19.57M(-47.1%)
$117.71M(-21.8%)
Dec 2019
$150.45M(+6.2%)
$36.98M(+54.7%)
$150.45M(-10.5%)
Sep 2019
-
$23.90M(-35.9%)
$168.08M(-0.6%)
Jun 2019
-
$37.27M(-28.7%)
$169.11M(+1.7%)
Mar 2019
-
$52.30M(-4.2%)
$166.21M(+17.3%)
Dec 2018
$141.73M(-50.4%)
$54.61M(+119.1%)
$141.73M(-47.4%)
Sep 2018
-
$24.93M(-27.5%)
$269.19M(-10.2%)
Jun 2018
-
$34.37M(+23.5%)
$299.66M(+2.9%)
Mar 2018
-
$27.82M(-84.7%)
$291.26M(+2.0%)
Dec 2017
$285.46M(+151.5%)
$182.08M(+228.7%)
$285.46M(+112.4%)
Sep 2017
-
$55.40M(+113.4%)
$134.39M(+32.1%)
Jun 2017
-
$25.96M(+17.9%)
$101.71M(+0.9%)
Mar 2017
-
$22.02M(-29.0%)
$100.77M(-11.2%)
Dec 2016
$113.48M(+7.3%)
$31.00M(+36.5%)
$113.48M(-10.1%)
Sep 2016
-
$22.72M(-9.2%)
$126.28M(+6.9%)
Jun 2016
-
$25.03M(-28.0%)
$118.17M(-8.0%)
Mar 2016
-
$34.74M(-20.7%)
$128.38M(+21.3%)
Dec 2015
$105.81M(+101.2%)
$43.80M(+200.0%)
$105.81M(+22.7%)
Sep 2015
-
$14.60M(-58.6%)
$86.24M(+6.3%)
Jun 2015
-
$35.24M(+189.5%)
$81.11M(+39.1%)
Mar 2015
-
$12.17M(-49.8%)
$58.33M(+10.9%)
Dec 2014
$52.60M
$24.23M(+156.0%)
$52.60M(+40.9%)
Sep 2014
-
$9.46M(-24.0%)
$37.33M(-13.6%)
DateAnnualQuarterlyTTM
Jun 2014
-
$12.46M(+93.3%)
$43.20M(-1.6%)
Mar 2014
-
$6.45M(-28.0%)
$43.90M(-9.6%)
Dec 2013
$48.55M(+17.8%)
$8.96M(-41.6%)
$48.55M(-20.1%)
Sep 2013
-
$15.33M(+16.4%)
$60.73M(+20.2%)
Jun 2013
-
$13.17M(+18.7%)
$50.51M(+12.4%)
Mar 2013
-
$11.10M(-47.5%)
$44.96M(+9.0%)
Dec 2012
$41.23M(-26.1%)
$21.14M(+313.9%)
$41.23M(+83.7%)
Sep 2012
-
$5.11M(-32.9%)
$22.45M(-44.3%)
Jun 2012
-
$7.61M(+3.3%)
$40.27M(-27.7%)
Mar 2012
-
$7.37M(+212.9%)
$55.67M(-0.3%)
Dec 2011
$55.83M(+341.7%)
$2.35M(-89.7%)
$55.83M(-0.6%)
Sep 2011
-
$22.93M(-0.3%)
$56.16M(+53.4%)
Jun 2011
-
$23.01M(+205.5%)
$36.62M(+118.8%)
Mar 2011
-
$7.53M(+180.7%)
$16.73M(+32.4%)
Dec 2010
$12.64M(-5.4%)
$2.68M(-20.8%)
$12.64M(-22.2%)
Sep 2010
-
$3.39M(+8.3%)
$16.24M(+2.9%)
Jun 2010
-
$3.13M(-8.9%)
$15.78M(+12.5%)
Mar 2010
-
$3.44M(-45.3%)
$14.03M(+5.0%)
Dec 2009
$13.36M(+58.4%)
$6.28M(+114.7%)
$13.36M(+33.5%)
Sep 2009
-
$2.93M(+111.9%)
$10.01M(+6.3%)
Jun 2009
-
$1.38M(-50.1%)
$9.42M(-0.2%)
Mar 2009
-
$2.77M(-5.7%)
$9.43M(+11.9%)
Dec 2008
$8.43M(+136.9%)
$2.93M(+25.9%)
$8.43M(+23.9%)
Sep 2008
-
$2.33M(+66.9%)
$6.81M(+27.0%)
Jun 2008
-
$1.40M(-21.0%)
$5.36M(+16.6%)
Mar 2008
-
$1.77M(+35.1%)
$4.59M(+29.1%)
Dec 2007
$3.56M(+553.3%)
$1.31M(+48.1%)
$3.56M(+35.1%)
Sep 2007
-
$883.40K(+39.6%)
$2.64M(+49.9%)
Jun 2007
-
$633.00K(-13.8%)
$1.76M(+43.1%)
Mar 2007
-
$734.00K(+90.7%)
$1.23M(+125.5%)
Dec 2006
$544.80K(+624.5%)
$384.90K(+5914.1%)
$544.70K(+179.6%)
Sep 2006
-
$6400.00(-93.8%)
$194.80K(-4.5%)
Jun 2006
-
$103.10K(+105.0%)
$204.00K(+62.4%)
Mar 2006
-
$50.30K(+43.7%)
$125.60K(+66.8%)
Dec 2005
$75.20K(>+9900.0%)
$35.00K(+124.4%)
$75.30K(+86.8%)
Sep 2005
-
$15.60K(-36.8%)
$40.30K(+63.2%)
Jun 2005
-
$24.70K(>+9900.0%)
$24.70K(-193.6%)
Dec 2003
$0.00(0.0%)
-
-
Jun 2003
-
$0.00(-100.0%)
-$26.40K(<-9900.0%)
Dec 2002
$0.00(-100.0%)
-$39.50K(-401.5%)
$100.00(-99.7%)
Sep 2002
-
$13.10K(+3175.0%)
$39.60K(+49.4%)
Jun 2002
-
$400.00(-98.5%)
$26.50K(+1.5%)
Mar 2002
-
$26.10K
$26.10K
Dec 2001
$8800.00
-
-

FAQ

  • What is Halozyme Therapeutics annual gross profit?
  • What is the all time high annual gross profit for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual gross profit year-on-year change?
  • What is Halozyme Therapeutics quarterly gross profit?
  • What is the all time high quarterly gross profit for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly gross profit year-on-year change?
  • What is Halozyme Therapeutics TTM gross profit?
  • What is the all time high TTM gross profit for Halozyme Therapeutics?
  • What is Halozyme Therapeutics TTM gross profit year-on-year change?

What is Halozyme Therapeutics annual gross profit?

The current annual gross profit of HALO is $855.91M

What is the all time high annual gross profit for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual gross profit is $855.91M

What is Halozyme Therapeutics annual gross profit year-on-year change?

Over the past year, HALO annual gross profit has changed by +$219.01M (+34.39%)

What is Halozyme Therapeutics quarterly gross profit?

The current quarterly gross profit of HALO is $216.46M

What is the all time high quarterly gross profit for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly gross profit is $255.95M

What is Halozyme Therapeutics quarterly gross profit year-on-year change?

Over the past year, HALO quarterly gross profit has changed by +$48.91M (+29.19%)

What is Halozyme Therapeutics TTM gross profit?

The current TTM gross profit of HALO is $904.82M

What is the all time high TTM gross profit for Halozyme Therapeutics?

Halozyme Therapeutics all-time high TTM gross profit is $904.82M

What is Halozyme Therapeutics TTM gross profit year-on-year change?

Over the past year, HALO TTM gross profit has changed by +$227.35M (+33.56%)
On this page